Table 3.
Risk Factors Associated with the Prevalence of Atherosclerosis in the Training Set
| Characteristics | Model 1 | Characteristics | Model 2 | ||
|---|---|---|---|---|---|
| P-value | OR (95% CI) | P-value | OR (95% CI) | ||
| Female (vs males) | <0.001 | 0.377(0.255–0.559) | Female (vs males) | <0.001 | 0.400(0.257–0.623) |
| Age, >65 years (vs ≤65 years) | <0.001 | 1.088(1.073–1.104) | Age, >65 years (vs ≤65 years) | <0.001 | 1.085(1.068–1.102) |
| CKD stage 3 (vs stage 1–2) | 0.026 | 2.040(1.091–3.816) | CKD stage 3 (vs stage 1–2) | 0.006 | 2.393(1.279–4.475) |
| CKD stage 4 (vs stage 1–2) | 0.193 | 1.522(0.809–2.864) | CKD stage 4 (vs stage 1–2) | 0.011 | 2.249(1.245–4.062) |
| CKD stage 5 (vs stage 1–2) | 0.026 | 1.913(1.082–3.382) | CKD stage 5 (vs stage 1–2) | 0.007 | 2.293(1.210–4.342) |
| Hypertension | 0.034 | 1.547(1.034–2.315) | Hypertension | 0.002 | 1.980(1.282–3.058) |
| Diabetes | 0.002 | 1.798(1.242–2.602) | Diabetes | 0.001 | 2.013(1.315–3.083) |
| Albumin, g/L | 0.001 | 0.963(0.941–0.986) | |||
| Calcium, mmol/L | 0.043 | 2.488(1.027–6.028) | |||
| Platelet counts, 109/L | 0.011 | 0.998(0.996–0.999) | |||